Apellis Pharmaceuticals, Inc. (APLS) came out with a quarterly loss of $0.54 per share in line with the Zacks Consensus Estimate. This compares to loss of$1.56 per share a year ago. These figures are adjusted for non- recurring items. A quarter ago, it was expected that this company would post a loss of $0.66 per share when it actually produced a loss of$0.73, delivering a surprise of -10.61%. Over the last four quarters, the company has surpassed consensus EPS estimates just once. Apellis Pharmaceuticals ...